Editorial: Oncogenic PI3KT/Akt/mTOR pathway alterations, ROS homeostasis, targeted cancer therapy and drug resistance.
作者信息
Pedrosa Rozangela C, Felipe Karina B, Wilhelm Filho Danilo
机构信息
Laboaratory of Experimental Biochemistry, Department of Ecology and Zoology, Federal University of Santa Catarina, Florianopolis, Santa Catarina, Brazil.
Laboratory of Physiology and Cell Signaling, Department of Clinical Analyses, Federal University of Parana, Curitiba, Parana, Brazil.
出版信息
Front Oncol. 2024 Feb 16;14:1372376. doi: 10.3389/fonc.2024.1372376. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: Oncogenic PI3KT/Akt/mTOR pathway alterations, ROS homeostasis, targeted cancer therapy and drug resistance.社论：致癌性PI3KT/Akt/mTOR信号通路改变、活性氧稳态、靶向癌症治疗与耐药性
Front Oncol. 2024 Feb 16;14:1372376. doi: 10.3389/fonc.2024.1372376. eCollection 2024.
2
PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?PI3K/Akt/mTOR信号通路及其在癌症治疗中的作用：我们有进展吗？
Front Oncol. 2022 Mar 24;12:819128. doi: 10.3389/fonc.2022.819128. eCollection 2022.
3
The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling.PI3K-AKT-mTOR 通路与前列腺癌：AR、MAPK 和 WNT 信号的十字路口。
Int J Mol Sci. 2020 Jun 25;21(12):4507. doi: 10.3390/ijms21124507.
4
Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer.针对人类癌症的靶向治疗，攻击 PI3K/Akt/mTOR 信号通路。
Semin Cancer Biol. 2022 Oct;85:69-94. doi: 10.1016/j.semcancer.2021.06.019. Epub 2021 Jun 25.
5
The PI3K/Akt/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles.肺癌中的PI3K/Akt/mTOR信号通路；致癌改变、治疗机遇、挑战以及纳米颗粒应用概述
Transl Oncol. 2022 Apr;18:101364. doi: 10.1016/j.tranon.2022.101364. Epub 2022 Feb 12.
6
The PI3K/Akt/mTOR axis in colorectal cancer: Oncogenic alterations, non-coding RNAs, therapeutic opportunities, and the emerging role of nanoparticles.结直肠癌中的PI3K/Akt/mTOR轴：致癌改变、非编码RNA、治疗机会及纳米颗粒的新作用
J Cell Physiol. 2022 Mar;237(3):1720-1752. doi: 10.1002/jcp.30655. Epub 2021 Dec 12.
7
Luteoloside induces G/G arrest and pro-death autophagy through the ROS-mediated AKT/mTOR/p70S6K signalling pathway in human non-small cell lung cancer cell lines.木犀草苷通过活性氧介导的AKT/mTOR/p70S6K信号通路诱导人非小细胞肺癌细胞系发生G/G期阻滞和促死亡自噬。
Biochem Biophys Res Commun. 2017 Dec 9;494(1-2):263-269. doi: 10.1016/j.bbrc.2017.10.042. Epub 2017 Oct 9.
8
Activation of PI3K/AKT/mTOR Pathway Causes Drug Resistance in Breast Cancer.PI3K/AKT/mTOR通路的激活导致乳腺癌耐药。
Front Pharmacol. 2021 Mar 15;12:628690. doi: 10.3389/fphar.2021.628690. eCollection 2021.
9
Cr(VI)-Induced Autophagy Protects L-02 Hepatocytes from Apoptosis Through the ROS-AKT-mTOR Pathway.六价铬诱导的自噬通过ROS-AKT-mTOR途径保护L-02肝细胞免受凋亡。
Cell Physiol Biochem. 2018;51(4):1863-1878. doi: 10.1159/000495713. Epub 2018 Nov 30.
10
High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors.循环肿瘤细胞衍生自结直肠癌患者，对 AKT 和 mTOR 抑制剂的双重抑制具有高敏感性。
Cells. 2020 Sep 20;9(9):2129. doi: 10.3390/cells9092129.
引用本文的文献
1
Role of signaling pathways in endometrial cancer.信号通路在子宫内膜癌中的作用。
Mol Biol Rep. 2025 Apr 21;52(1):408. doi: 10.1007/s11033-025-10523-1.
2
Synergistic effects of 6-shogaol and hyperthermia on ACHN renal cancer cells: modulation of ROS and heat shock pro-teins in cancer therapy.6-姜辣素与热疗对ACHN肾癌细胞的协同作用：癌症治疗中活性氧和热休克蛋白的调节
Front Pharmacol. 2025 Feb 20;16:1522285. doi: 10.3389/fphar.2025.1522285. eCollection 2025.
3
Application of Multifunctional Metal Nanoparticles in the Treatment of Glioma.多功能金属纳米粒子在神经胶质瘤治疗中的应用
Int J Nanomedicine. 2025 Jan 16;20:625-638. doi: 10.2147/IJN.S493565. eCollection 2025.
Zotero 插件